APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiation Injury Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Radiation Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025185 pages

Choose your research edition.

Industry ResearchRadiation Injury Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiation Injury Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Radiation Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiation Injury Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiation Injury Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Radiation Injury Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiation Injury Drugs include Windtree Therapeutics Inc, Tonix Pharmaceuticals Holding Corp, Synedgen Inc, PharmaIN Corp and FirstString Research Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radiation Injury Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiation Injury Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiation Injury Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiation Injury Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiation Injury Drugs Segment by Company

Windtree Therapeutics Inc

Tonix Pharmaceuticals Holding Corp

Synedgen Inc

PharmaIN Corp

FirstString Research Inc

Radiation Injury Drugs Segment by Type

DG-3

Des-Asp Angiotensin 1

C-2E5

C-2E2

BMX-001

Aerosurf

Others

Radiation Injury Drugs Segment by Application

Hospital

Clinic

ASCs

Others

Radiation Injury Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiation Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Injury Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiation Injury Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiation Injury Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Radiation Injury Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Radiation Injury Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Radiation Injury Drugs Industry Trends Table 2. Radiation Injury Drugs Industry Drivers Table 3. Radiation Injury Drugs Industry Opportunities and Challenges Table 4. Radiation Injury Drugs Industry Restraints Table 5. Global Radiation Injury Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Radiation Injury Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Radiation Injury Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Radiation Injury Drugs Sales Market Share by Manufacturers Table 9. Global Radiation Injury Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Radiation Injury Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Radiation Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Radiation Injury Drugs Manufacturers, Product Type & Application Table 13. Global Radiation Injury Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiation Injury Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DG-3 Table 17. Major Manufacturers of Des-Asp Angiotensin 1 Table 18. Major Manufacturers of C-2E5 Table 19. Major Manufacturers of C-2E2 Table 20. Major Manufacturers of BMX-001 Table 21. Major Manufacturers of Aerosurf Table 22. Major Manufacturers of Others Table 23. Global Radiation Injury Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 25. Global Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 26. Global Radiation Injury Drugs Sales Market Share by Type (2021-2026) Table 27. Global Radiation Injury Drugs Sales Market Share by Type (2027-2032) Table 28. Global Radiation Injury Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Radiation Injury Drugs Revenue by Type (2021-2026) & (K Units) Table 30. Global Radiation Injury Drugs Revenue by Type (2027-2032) & (K Units) Table 31. Global Radiation Injury Drugs Revenue Market Share by Type (2021-2026) Table 32. Global Radiation Injury Drugs Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Clinic Table 35. Major Manufacturers of ASCs Table 36. Major Manufacturers of Others Table 37. Global Radiation Injury Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 39. Global Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 40. Global Radiation Injury Drugs Sales Market Share by Application (2021-2026) Table 41. Global Radiation Injury Drugs Sales Market Share by Application (2027-2032) Table 42. Global Radiation Injury Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Radiation Injury Drugs Revenue by Application (2021-2026) & (K Units) Table 44. Global Radiation Injury Drugs Revenue by Application (2027-2032) & (K Units) Table 45. Global Radiation Injury Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Radiation Injury Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Radiation Injury Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Radiation Injury Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Radiation Injury Drugs Sales Market Share by Region (2021-2026) Table 50. Global Radiation Injury Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Radiation Injury Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 54. North America Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 55. Europe Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 57. Europe Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Radiation Injury Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Radiation Injury Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Radiation Injury Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Radiation Injury Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Radiation Injury Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Radiation Injury Drugs Revenue Market Share by Region (2027-2032) Table 69. Windtree Therapeutics Inc Company Information Table 70. Windtree Therapeutics Inc Business Overview Table 71. Windtree Therapeutics Inc Radiation Injury Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio Table 73. Windtree Therapeutics Inc Recent Development Table 74. Tonix Pharmaceuticals Holding Corp Company Information Table 75. Tonix Pharmaceuticals Holding Corp Business Overview Table 76. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio Table 78. Tonix Pharmaceuticals Holding Corp Recent Development Table 79. Synedgen Inc Company Information Table 80. Synedgen Inc Business Overview Table 81. Synedgen Inc Radiation Injury Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Synedgen Inc Radiation Injury Drugs Product Portfolio Table 83. Synedgen Inc Recent Development Table 84. PharmaIN Corp Company Information Table 85. PharmaIN Corp Business Overview Table 86. PharmaIN Corp Radiation Injury Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. PharmaIN Corp Radiation Injury Drugs Product Portfolio Table 88. PharmaIN Corp Recent Development Table 89. FirstString Research Inc Company Information Table 90. FirstString Research Inc Business Overview Table 91. FirstString Research Inc Radiation Injury Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. FirstString Research Inc Radiation Injury Drugs Product Portfolio Table 93. FirstString Research Inc Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Radiation Injury Drugs Distributors List Table 97. Radiation Injury Drugs Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Radiation Injury Drugs Product Image Figure 2. Global Radiation Injury Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiation Injury Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiation Injury Drugs Sales (2021-2032) & (K Units) Figure 5. Global Radiation Injury Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Radiation Injury Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DG-3 Image Figure 9. Des-Asp Angiotensin 1 Image Figure 10. C-2E5 Image Figure 11. C-2E2 Image Figure 12. BMX-001 Image Figure 13. Aerosurf Image Figure 14. Others Image Figure 15. Global Radiation Injury Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Radiation Injury Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Radiation Injury Drugs Sales Market Share by Type (2021-2032) Figure 18. Global Radiation Injury Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Radiation Injury Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Radiation Injury Drugs Revenue Market Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. ASCs Image Figure 24. Others Image Figure 25. Global Radiation Injury Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Radiation Injury Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Radiation Injury Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Radiation Injury Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Radiation Injury Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Radiation Injury Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Radiation Injury Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Radiation Injury Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Radiation Injury Drugs Sales Market Share by Country (2021-2032) Figure 45. China Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Radiation Injury Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Radiation Injury Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Radiation Injury Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Radiation Injury Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Radiation Injury Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Radiation Injury Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Radiation Injury Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • DG-3
  • Des-Asp Angiotensin 1
  • C-2E5
  • C-2E2
  • BMX-001
  • Aerosurf
  • Others
Applications
  • Hospital
  • Clinic
  • ASCs
  • Others
Companies covered
  • Windtree Therapeutics Inc
  • Tonix Pharmaceuticals Holding Corp
  • Synedgen Inc
  • PharmaIN Corp
  • FirstString Research Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiation Injury Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiation Injury Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Radiation Injury Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Radiation Injury Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Radiation Injury Drugs Market Dynamics
  1. 2.1 Radiation Injury Drugs Industry Trends
  2. 2.2 Radiation Injury Drugs Industry Drivers
  3. 2.3 Radiation Injury Drugs Industry Opportunities and Challenges
  4. 2.4 Radiation Injury Drugs Industry Restraints
3 Radiation Injury Drugs Market by Manufacturers
  1. 3.1 Global Radiation Injury Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Radiation Injury Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Radiation Injury Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Radiation Injury Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiation Injury Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Radiation Injury Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Radiation Injury Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiation Injury Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiation Injury Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiation Injury Drugs Tier 1, Tier 2, and Tier 3
4 Radiation Injury Drugs Market by Type
  1. 4.1 Radiation Injury Drugs Type Introduction
  2. 4.1.1 DG-3
  3. 4.1.2 Des-Asp Angiotensin 1
  4. 4.1.3 C-2E5
  5. 4.1.4 C-2E2
  6. 4.1.5 BMX-001
  7. 4.1.6 Aerosurf
  8. 4.1.7 Others
  9. 4.2 Global Radiation Injury Drugs Sales by Type
  10. 4.2.1 Global Radiation Injury Drugs Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Radiation Injury Drugs Sales by Type (2021-2032)
  12. 4.2.3 Global Radiation Injury Drugs Sales Market Share by Type (2021-2032)
  13. 4.3 Global Radiation Injury Drugs Revenue by Type
  14. 4.3.1 Global Radiation Injury Drugs Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Radiation Injury Drugs Revenue by Type (2021-2032)
  16. 4.3.3 Global Radiation Injury Drugs Revenue Market Share by Type (2021-2032)
5 Radiation Injury Drugs Market by Application
  1. 5.1 Radiation Injury Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 ASCs
  5. 5.1.4 Others
  6. 5.2 Global Radiation Injury Drugs Sales by Application
  7. 5.2.1 Global Radiation Injury Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Radiation Injury Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Radiation Injury Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Radiation Injury Drugs Revenue by Application
  11. 5.3.1 Global Radiation Injury Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Radiation Injury Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Radiation Injury Drugs Revenue Market Share by Application (2021-2032)
6 Global Radiation Injury Drugs Sales by Region
  1. 6.1 Global Radiation Injury Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiation Injury Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Radiation Injury Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Radiation Injury Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Radiation Injury Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Radiation Injury Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Radiation Injury Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Radiation Injury Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Radiation Injury Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Radiation Injury Drugs Revenue by Region
  1. 7.1 Global Radiation Injury Drugs Revenue by Region
  2. 7.1.1 Global Radiation Injury Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Radiation Injury Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Radiation Injury Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Radiation Injury Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Radiation Injury Drugs Revenue (2021-2032)
  8. 7.2.2 North America Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Radiation Injury Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Radiation Injury Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Radiation Injury Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Radiation Injury Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Windtree Therapeutics Inc
  2. 8.1.1 Windtree Therapeutics Inc Company Information
  3. 8.1.2 Windtree Therapeutics Inc Business Overview
  4. 8.1.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio
  6. 8.1.5 Windtree Therapeutics Inc Recent Developments
  7. 8.2 Tonix Pharmaceuticals Holding Corp
  8. 8.2.1 Tonix Pharmaceuticals Holding Corp Company Information
  9. 8.2.2 Tonix Pharmaceuticals Holding Corp Business Overview
  10. 8.2.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio
  12. 8.2.5 Tonix Pharmaceuticals Holding Corp Recent Developments
  13. 8.3 Synedgen Inc
  14. 8.3.1 Synedgen Inc Company Information
  15. 8.3.2 Synedgen Inc Business Overview
  16. 8.3.3 Synedgen Inc Radiation Injury Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Synedgen Inc Radiation Injury Drugs Product Portfolio
  18. 8.3.5 Synedgen Inc Recent Developments
  19. 8.4 PharmaIN Corp
  20. 8.4.1 PharmaIN Corp Company Information
  21. 8.4.2 PharmaIN Corp Business Overview
  22. 8.4.3 PharmaIN Corp Radiation Injury Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PharmaIN Corp Radiation Injury Drugs Product Portfolio
  24. 8.4.5 PharmaIN Corp Recent Developments
  25. 8.5 FirstString Research Inc
  26. 8.5.1 FirstString Research Inc Company Information
  27. 8.5.2 FirstString Research Inc Business Overview
  28. 8.5.3 FirstString Research Inc Radiation Injury Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FirstString Research Inc Radiation Injury Drugs Product Portfolio
  30. 8.5.5 FirstString Research Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiation Injury Drugs Value Chain Analysis
  2. 9.1.1 Radiation Injury Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiation Injury Drugs Production Mode & Process
  6. 9.2 Radiation Injury Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiation Injury Drugs Distributors
  9. 9.2.3 Radiation Injury Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst